Prospective, multicenter clinical trial comparing the M6-C compressible cervical disc with anterior cervical discectomy and fusion for the treatment of single-level degenerative cervical radiculopathy: 5-year results of an FDA investigational device exemption study

医学 颈椎前路椎间盘切除融合术 试验装置豁免 临床终点 背景(考古学) 外科 临床试验 颈部疼痛 生活质量(医疗保健) 随机对照试验 内科学 颈椎 替代医学 护理部 古生物学 病理 生物
作者
Frank M. Phillips,Domagoj Coric,Rick Sasso,Todd H. Lanman,William F. Lavelle,Carl Lauryssen,Todd J. Albert,Frank P. Cammisa,R. Alden Milam
出处
期刊:The Spine Journal [Elsevier BV]
卷期号:24 (2): 219-230 被引量:1
标识
DOI:10.1016/j.spinee.2023.10.020
摘要

BACKGROUND CONTEXT : Various total disc replacement (TDR) designs have been compared to anterior cervical discectomy and fusion (ACDF) with favorable short and long-term outcomes in FDA-approved investigational device exemption (IDE) trials. The unique design of M6-C, with a compressible viscoelastic nuclear core and an annular structure, has previously demonstrated favorable clinical outcomes through 24 months. PURPOSE : To evaluate the long-term safety and effectiveness of the M6-C compressible artificial cervical disc and compare to ACDF at 5 years. STUDY DESIGN : Prospective, multicenter, concurrently and historically controlled, FDA-approved IDE clinical trial. PATIENT SAMPLE : Subjects with one-level symptomatic degenerative cervical radiculopathy were enrolled and received M6-C (n = 160) or ACDF (n = 189) treatment as part of the IDE study. Safety outcomes were evaluated at 5 years for all subjects. The primary effectiveness endpoint was available at 5 years for 113 M6-C subjects and 106 ACDF controls. OUTCOME MEASURES : The primary endpoint of this analysis was composite clinical success (CCS) at 60 months. Secondary endpoints were function and pain (Neck Disability Index, VAS), physical quality of life (SF-36, SF-12), safety, neurologic, and radiographic assessments. METHODS : Propensity score subclassification was used to control for selection bias and match baseline covariates of the control group to the M6-C subjects. Sixty-month CCS rates were estimated for each treatment group using a generalized linear model controlling for propensity score. RESULTS : At 5 years post-operatively, the M6-C treatment resulted in 82.3% CCS while the ACDF group showed 67.0% CCS (superiority p = 0.013). Secondary endpoints indicated that significantly more M6-C subjects achieved VAS neck and arm pain improvements and showed maintained or improved physical functioning on quality of life measures compared to baseline assessments. The M6-C group maintained flexion-extension motion, with significantly greater increases from baseline disc height and disc angle than observed in the control group. The rates of M6-C subsequent surgical interventions (SSI; 3.1%) and definitely device- or procedure-related serious adverse events (SAE failure; 3.1%) were similar to ACDF rates (SSI = 5.3%, SAE failure = 4.8%; p > 0.05 for both). CONCLUSIONS : Subjects treated with the M6-C artificial disc demonstrated superior 5-year achievement of clinical success when compared to ACDF controls. In addition, significantly more subjects in the M6-C group showed improved pain and physical functioning scores than observed in ACDF subjects, with no difference in re-operation rates or safety outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
平常的外套完成签到 ,获得积分10
刚刚
jin完成签到,获得积分10
1秒前
1秒前
谷谷完成签到,获得积分20
1秒前
曾经焦焦完成签到,获得积分10
1秒前
无私的难胜完成签到 ,获得积分10
2秒前
领导范儿的应助被aaa材料采纳,获得10
2秒前
2秒前
毛毛余完成签到 ,获得积分10
2秒前
小屁孩完成签到,获得积分10
2秒前
Orange的应助被Len采纳,获得30
2秒前
mxd1991完成签到,获得积分10
3秒前
yukirao完成签到,获得积分10
3秒前
loudei发布了新的文献求助10
3秒前
研友_5Z4ZA5完成签到,获得积分10
3秒前
脑洞疼的应助被风吹麦浪采纳,获得10
3秒前
无花果的应助被KK采纳,获得10
3秒前
3秒前
4秒前
无极微光的应助被yulu采纳,获得20
4秒前
SM俊完成签到,获得积分10
4秒前
4秒前
molihuakai的应助被董家旭采纳,获得10
4秒前
huww发布了新的文献求助10
5秒前
5秒前
哈哈哈完成签到 ,获得积分10
5秒前
luchong发布了新的文献求助10
5秒前
英吉利25发布了新的文献求助10
5秒前
坦诚发布了新的文献求助10
5秒前
6秒前
雾雪零尘完成签到,获得积分10
7秒前
透射电镜完成签到,获得积分10
7秒前
呼呼哈哈发布了新的文献求助50
7秒前
田様的应助被曾经焦焦采纳,获得10
8秒前
麦当当发布了新的文献求助10
8秒前
噜噜啦完成签到 ,获得积分10
8秒前
彭于彦祖的应助被zzZ5采纳,获得30
8秒前
8秒前
9秒前
qearl发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253